Physician

Frederick Dold, M.D.

According to 2025 Medicare claims, Frederick Dold, M.D. (NPI: 1174638597) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19020-6415.

Dold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 410 traditional Medicare patients, billed 132,455 HCPCS/CPT codes, and received $2,709,120 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 580 prescription claims across 134 beneficiaries totaling $1,588,437 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 36 claims. Open Payments data shows 117 records totaling $2,745. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,261,483 to $2,709,120. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $628,281 to $1,588,437. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $1,261,483 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,235,788 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,194,001 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,971,103 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,907,429 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,657,700 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,209,375 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,115,350 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,856,591 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,709,120 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201530668,266$1,261,483
201626882,793$1,235,788
201725082,254$1,194,001
2018262109,059$1,971,103
201928994,589$1,907,429
2020318118,147$2,657,700
2021395162,455$2,209,375
2022315146,333$2,115,350
2023348192,379$2,856,591
2024410132,455$2,709,120

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.5M2015 Drug cost: $628,281 (USD; Tot_Drug_Cst)2016 Drug cost: $593,323 (USD; Tot_Drug_Cst)2017 Drug cost: $882,405 (USD; Tot_Drug_Cst)2018 Drug cost: $1,044,897 (USD; Tot_Drug_Cst)2019 Drug cost: $1,321,276 (USD; Tot_Drug_Cst)2020 Drug cost: $1,891,582 (USD; Tot_Drug_Cst)2021 Drug cost: $2,502,465 (USD; Tot_Drug_Cst)2022 Drug cost: $1,854,101 (USD; Tot_Drug_Cst)2023 Drug cost: $1,553,846 (USD; Tot_Drug_Cst)2024 Drug cost: $1,588,437 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015116597$628,281
2016100444$593,323
201796481$882,405
2018110506$1,044,897
2019120523$1,321,276
2020123702$1,891,582
2021130699$2,502,465
2022117640$1,854,101
2023114636$1,553,846
2024134580$1,588,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.6K$9.1K2015 Medicare payment: $9,120 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $625 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $612 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,801 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,273 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,583 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R37$9,120
2016N/R22$625
2017N/RN/RN/R
2018N/R12$612
2019N/R15$1,801
2020N/R45$5,273
2021N/R36$3,583
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more195443$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more105149$65
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less79176$23
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's236438$13
96372Injection of drug or substance under skin or into muscle77353$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide371,015$662,255
XtandiEnzalutamide14420$186,336
VenclextaVenetoclax13378$146,061
OrgovyxRelugolix11328$29,356
XareltoRivaroxaban491,440$27,328

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.117$2,745Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Frederick Dold, M.D.?

Tedicare shows public-source Medicare data for Frederick Dold, M.D. (NPI 1174638597), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frederick Dold, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frederick Dold, M.D.?

Frederick Dold, M.D. is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Frederick Dold, M.D. have Open Payments data?

Frederick Dold, M.D. has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.